U.S. EPA issues proposed registration review decisions for several pesticides

On July 13, 2022, the U.S. EPA released the proposed interim decisions for pesticides undergoing registration review as part of fiscal year 2022 quarter 3 actions. The Federal Insecticide, Fungicide and Rodenticide Act (FIFRA) requires EPA to review pesticides every 15 years to ensure that risk assessments reflect the best-available science. 

Registration review ensures that, as the ability to assess risk evolves and as policies and practices change, the pesticide continues to meet the statutory standard of causing no unreasonable adverse effects on human health or the environment. When EPA identifies risks of concern to human health or the environment, it amends pesticide labels to mitigate these risks.  

The proposed interim decisions (PIDs) propose mitigation measures based on findings in the draft human health and ecological risk assessments (DRAs) and feedback submitted during the DRAs’ public comment period. The PIDs released today are for the following pesticides:

Biopesticides:

• 2-methyl-1-butanol; 

• Calcium acetate;

• Candida oleophilaI;

• Cedarwood oil;  

• Citral; 

• Heptyl butyrate; and 

• l-carvone.

Conventional pesticides:

• Chlorflurenol methyl ester; 

• Sedaxane; 

• Tebuconazole; and 

• Triadimefon and Triadimenol.

With the publication of the Federal Register notice, the PIDs are now available for public comment in each respective pesticide registration review docket at www.regulations.gov. Public comments will be accepted for 60 days.

After considering comments on the PIDs, the next step in the registration review process will be the interim decision, which finalizes any required risk mitigation measures to address human health and ecological risks of concern.  

Visit EPA’s website for more information on the registration review process and the schedule of upcoming registration review actions.